KP-46

N/A

Report date: 2024/11/21 20:00:04

Base Information

Drug NameKP-46
Drug Alias NameKP-46FFC-11LX-001AP-002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBone resorption factor inhibitorsOsteoblasts stimulantsTumor necrosis factor ligand superfamily member 11 inhibitors
TargetsBone resorption factorTumor necrosis factor ligand superfamily member 11
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of HeidelbergMeram
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAltum Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A